Transgene Sa Stock Price Prediction

TRGNF Stock  USD 1.59  0.00  0.00%   
As of 2nd of December 2024 the relative strength index (rsi) of Transgene's share price is below 20 . This usually implies that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

0

 
Oversold
 
Overbought
The successful prediction of Transgene's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Transgene and does not consider all of the tangible or intangible factors available from Transgene's fundamental data. We analyze noise-free headlines and recent hype associated with Transgene SA, which may create opportunities for some arbitrage if properly timed.
Using Transgene hype-based prediction, you can estimate the value of Transgene SA from the perspective of Transgene response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Transgene to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Transgene because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Transgene after-hype prediction price

    
  USD 1.59  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Transgene Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
1.591.591.59
Details
Naive
Forecast
LowNextHigh
1.591.591.59
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.591.591.59
Details

Transgene After-Hype Price Prediction Density Analysis

As far as predicting the price of Transgene at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Transgene or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Transgene, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Transgene Estimiated After-Hype Price Volatility

In the context of predicting Transgene's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Transgene's historical news coverage. Transgene's after-hype downside and upside margins for the prediction period are 1.59 and 1.59, respectively. We have considered Transgene's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.59
1.59
After-hype Price
1.59
Upside
Transgene is very steady at this time. Analysis and calculation of next after-hype price of Transgene SA is based on 3 months time horizon.

Transgene Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Transgene is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Transgene backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Transgene, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
2 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.59
1.59
0.00 
0.00  
Notes

Transgene Hype Timeline

Transgene SA is at this time traded for 1.59. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Transgene is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Transgene is about 0.0%, with the expected price after the next announcement by competition of 1.59. The company has price-to-book ratio of 0.02. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Transgene SA recorded a loss per share of 0.23. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next estimated press release will be within a week.
Check out Transgene Basic Forecasting Models to cross-verify your projections.

Transgene Related Hype Analysis

Having access to credible news sources related to Transgene's direct competition is more important than ever and may enhance your ability to predict Transgene's future price movements. Getting to know how Transgene's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Transgene may potentially react to the hype associated with one of its peers.

Transgene Additional Predictive Modules

Most predictive techniques to examine Transgene price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Transgene using various technical indicators. When you analyze Transgene charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Transgene Predictive Indicators

The successful prediction of Transgene stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Transgene SA, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Transgene based on analysis of Transgene hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Transgene's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Transgene's related companies.

Story Coverage note for Transgene

The number of cover stories for Transgene depends on current market conditions and Transgene's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Transgene is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Transgene's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Transgene Short Properties

Transgene's future price predictability will typically decrease when Transgene's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Transgene SA often depends not only on the future outlook of the potential Transgene's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Transgene's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding83.8 M

Complementary Tools for Transgene Pink Sheet analysis

When running Transgene's price analysis, check to measure Transgene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transgene is operating at the current time. Most of Transgene's value examination focuses on studying past and present price action to predict the probability of Transgene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transgene's price. Additionally, you may evaluate how the addition of Transgene to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Insider Screener
Find insiders across different sectors to evaluate their impact on performance